EU/3/13/1168

About

On 17 July 2013, orphan designation (EU/3/13/1168) was granted by the European Commission to University Newcastle upon Tyne, United Kingdom, for ex-vivo-expanded autologous human corneal epithelium containing stem cells for the treatment of limbal-stem-cell deficiency.

Key facts

Active substance
Ex-vivo-expanded autologous human corneal epithelium containing stem cells
Disease / condition
Treatment of limbal-stem-cell deficiency
Date of decision
17/07/2013
Outcome
Positive
Orphan decision number
EU/3/13/1168

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

University of Newcastle upon Tyne
Kings Gate
Newcastle upon Tyne
NE1 7RU
United Kingdom
Tel. +44 (0)191 208 434
Fax +44 (0)191 208 3245
E-mail: fmsenterprise@ncl.ac.uk

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating